NAD(P)H:quinone oxidoreductase 1 NQO1 * 2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer
2008
Jiri Bartek and colleagues find that a common variant reducing NAD(P)H:quinone oxidoreductase 1 activity is a potential predictor of response to epirubicin chemotherapy in women with breast cancer. Cell-based assays suggest three modes of action for the enzyme via the p53 and TNF–NF-κB pathways and by direct detoxification of reactive oxygen species.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
55
References
174
Citations
NaN
KQI